January 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreApril 21, 2026
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreApril 21, 2026
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreApril 21, 2026
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreApril 21, 2026
Projections indicate that, direct-to-consumer laboratory testing industry is projected to rise from USD 3.47 billion in 2024 to USD 8.16 billion by 2034, reflecting a CAGR of 8.94% over the next decade. The market is growing due to increasing consumer demand for convenient, at-home health insights and personalized care. Rising awareness of preventi...
April 21, 2026
Based on market forecasts, the non-invasive prenatal testing sector will expand from USD 6.45 billion in 2024 to USD 18.94 billion by 2034, experiencing a CAGR of 11.65%. The non-invasive prenatal testing market is growing due to the increasing demand for safer, earlier, and accurate detection of fetal genetic disorders. North America is dominating...
April 21, 2026
According to market projections, the U.S. point-of-care infectious disease testing market, valued at USD 2.1 billion in 2024, is anticipated to reach USD 5.01 billion by 2034, growing at a CAGR of 9.34% over the next decade. The expanding growth of point-of-care testing for infectious diseases in the U.S. is driven by improved patient outcomes, inc...
April 21, 2026
The dental panoramic X-ray market is growing because it is utilized when checking for jaw disorders, wisdom teeth, and issues involving sinuses and oral health. North America is dominant in the market due to its high consumer spending on dental care and huge adoption of advanced modern imaging technologies....
April 21, 2026
The global Pre-Dx oncology market is growing with rising cancer incidence and advanced early detection technologies. North America led with 45% share in 2024, while Asia Pacific is fastest-growing. Liquid biopsy tests accounted for 40% revenue, MCED tests show high CAGR, and NGS made up 38% of technology revenue. Blood and urine are key sample type...
April 21, 2026
The IVD diagnostic molecule raw enzymes market is valued at USD 2.39 billion in 2024, projected to reach USD 4.73 billion by 2034 at a 7.13% CAGR. It includes segmentation by enzyme type, application, and technology, with leading regions like North America (45.9%) and Asia Pacific. The study covers trade data, supply chain, key players like QIAGEN,...
April 13, 2026
Activated Clotting Time Testing Market (By Product: Consumables, ACT Analyzers; By Test Type: High-Range ACT Tests, Low-Range ACT Tests; By Application: Hemodialysis, Cardiovascular Surgery, Interventional Cardiology; By End-Use: Hospitals, Diagnostic Laboratories, Ambulatory Surgical Centers; By Region: North America, Asia Pacific, Europ...
April 09, 2026
Electrophysiology Market ( By Product Type: Electrophysiology Catheters, 3D Electroanatomic Mapping & Navigation Systems, Ablation Generators & Energy Sources, EP Recording Systems / Monitors, Intracardiac Echocardiography (ICE) & Imaging Accessories, Access Devices & Consumables; By Procedure Type / Indication: Atrial Fibrillation ...
April 02, 2026
Blood-Based Biomarker for Alzheimer’s Disease Diagnostics Market (By Biomarker Type: Amyloid-Based Biomarkers, Tau-Based Biomarkers, Neurodegeneration Biomarkers, Inflammatory Biomarkers, Other Emerging Biomarkers; By Technology Platform: Immunoassays, Mass Spectrometry, PCR-Based Assays, Next-Generation Sequencing, Biosensor-Based Platforms;...
March 31, 2026
Cancer Biomarkers Market (By Type: Breast cancer, Prostate cancer, Colorectal cancer, Cervical cancer, Liver cancer, Lung cancer, Others; By Biomolecule: Genetic Biomarkers, Epigenetic Biomarkers, Metabolic Biomarkers, Proteomic Biomarkers, Others; By Application: Drug Discovery and Development, Diagnostics, Personalized medicine, Other; By Technol...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
